Emmanuel Effa

Dr. Emmanuel Effa

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
UEUdeme E Ekrikpo
Udeme E Ekrikpo
AKAndre Pascal Kengne
Andre Pascal Kengne
ABAminu K Bello
Aminu K Bello
EEEmmanuel Effa
Emmanuel Effa
JNJoan Jacques Noubiap
Joan Jacques Noubiap
IOIkechi G Okpechi
Ikechi G Okpechi
The widespread use of antiretroviral therapies (ART) has increased life expectancy in HIV patients, predisposing them to chronic non-communicable diseases including Chronic Kidney Disease (CKD). We performed a systematic review and meta-analysis (PROSPERO registration number CRD42016036246) to determine the global and regional prevalence of CKD in HIV patients. We searched PubMed, Web of Science, EBSCO and AJOL for articles published between January 1982 and May 2016. CKD was defined as estimated glomerular filtration rate (eGFR) <60ml/min using the MDRD, Cockcroft-Gault or CKD-EPI equations. Random effects model was used to combine prevalence estimates from across studies after variance stabilization via Freeman–Tukey transformation. Sixty-one eligible articles (n = 209,078 HIV patients) in 60 countries were selected. The overall CKD prevalence was 6.4% (95%CI 5.2–7.7%) with MDRD, 4.8% (95%CI 2.9–7.1%) with CKD-EPI and 12.3% (95%CI 8.4–16.7%) with Cockcroft–Gault; p = 0.003 for difference across estimators. Sub-group analysis identified differences in prevalence by WHO region with Africa having the highest MDRD-based prevalence at 7.9% (95%CI 5.2–11.1%). Within Africa, the pooled MDRD-based prevalence was highest in West Africa [14.6% (95%CI 9.9–20.0%)] and lowest in Southern Africa (3.2%, 95%CI 3.0–3.4%). The heterogeneity observed could be explained by WHO region, comorbid hypertension and diabetes mellitus, but not by gender, hepatitis B or C coinfection, CD4 count or antiretroviral status. CKD is common in HIV-infected people, particularly in Africa. HIV treatment programs need to intensify screening for CKD with added need to introduce global guidelines for CKD identification and treatment in HIV positive patients.

8 October 2008
Verified
Reference Entry
Closed access
PDF file
EEEmmanuel Effa
Emmanuel Effa
HBHasifa Bukirwa
Hasifa Bukirwa

5 October 2011 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
EEEmmanuel Effa
Emmanuel Effa
ZLZohra S Lassi
Zohra S Lassi
JCJulia A Critchley
Julia A Critchley
PGPaul Garner
Paul Garner
DSDavid Sinclair
David Sinclair
ZBZulfiqar Bhutta
Zulfiqar Bhutta

28 July 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
BOBabasola O Okusanya
Babasola O Okusanya
OOOlabisi Oduwole
Olabisi Oduwole
EEEmmanuel Effa
Emmanuel Effa

24 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
SKSonagnon KOUHOUNDE
Sonagnon KOUHOUNDE
KAKifouli Adéoti
Kifouli Adéoti
MMMajid Mounir
Majid Mounir
AGAlessandro Giusti
Alessandro Giusti
PRPaulo Refinetti
Paulo Refinetti
HRHary Razafindralambo
Hary Razafindralambo
Probiotics and related preparations, including synbiotics and postbiotics, are living and non-living microbial-based multi-components, which are now among the most popular bioactive agents. Such interests mainly arise from the wide range and numerous beneficial effects of their use for various hosts. The current minireview article attempts to provide an overview and discuss in a holistic way the concepts, methodologies, action mechanisms, and applications of probiotic-based multi-components in human, animal, plant, soil, and environment health. Probiotic-based multi-component preparations refer to a mixture of bioactive agents, containing probiotics or postbiotics as main functional ingredients, and prebiotics, protectants, stabilizers, encapsulating agents, and other compounds as additional constituents. Analyzing, characterizing, and monitoring over time the traceability, performance, and stability of such multi-component ingredients require relevant and sensitive analytical tools and methodologies. Two innovative profiling and monitoring methods, the thermophysical fingerprinting thermogravimetry–differential scanning calorimetry technique (TGA-DSC) of the whole multi-component powder preparations, and the Advanced Testing for Genetic Composition (ATGC) strain analysis up to the subspecies level, are presented, illustrated, and discussed in this review to respond to those requirements. Finally, the paper deals with some selected applications of probiotic-based multi-components to human, animal, plant, soil and environment health, while mentioning their possible action mechanisms.

2 October 2011 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
UEUdeme E Ekrikpo
Udeme E Ekrikpo
AUAniema I Udo
Aniema I Udo
EIEnobong E Ikpeme
Enobong E Ikpeme
EEEmmanuel Effa
Emmanuel Effa
Haemodialysis is the most common form of renal replacement therapy in Nigeria. The high cost of haemodialysis has made optimal therapy of end-stage renal disease difficult in Nigeria. This paper is a review of data collected over two years of provision of dialysis services in a new tertiary hospital in Southern Nigeria.